Rocket Doctor Secures Funding to Drive U.S. Market Expansion and Product Innovation

Core Insights - Rocket Doctor AI Inc. has secured funding of up to $75,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) and $25,000 from the CanExport SMEs program to enhance its digital health platform and accelerate U.S. market growth [1][3] Funding and Development - The NRC IRAP funding will focus on developing a secure, PHIPA- and HIPAA-compliant messaging feature for the Rocket Doctor platform, enabling encrypted, real-time communication for up to 5,000 concurrent users and over 500 clinicians [2] - The CanExport funding will support U.S. expansion efforts, including the creation of marketing materials and targeted advertising in key states [3] Technical Enhancements - The new messaging feature will align with Ontario Health's Virtual Visit Solution standards and is expected to expedite the company's OTN certification timeline to Q1 2026, facilitating procurement by over 300 Ontario health service providers [2][4] - The enhancements are anticipated to create new technical roles in Canada and increase revenue potential through expanded public procurement eligibility in Ontario and new opportunities in the U.S. [4] Company Mission and Impact - Rocket Doctor AI aims to improve healthcare accessibility and equity, particularly for underserved communities in Canada and patients on Medicaid and Medicare in the U.S. [7] - The company leverages advanced AI and connected medical devices to redefine modern healthcare, making it more scalable and patient-centered [7]